↓ Skip to main content

Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance

Overview of attention for article published in Molecular Cancer Therapeutics, October 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (95th percentile)

Mentioned by

news
1 news outlet
twitter
17 X users
patent
4 patents

Citations

dimensions_citation
295 Dimensions

Readers on

mendeley
266 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance
Published in
Molecular Cancer Therapeutics, October 2016
DOI 10.1158/1535-7163.mct-16-0300
Pubmed ID
Authors

Ping Chen, Nathan V Lee, Wenyue Hu, Meirong Xu, Rose Ann Ferre, Hieu Lam, Simon Bergqvist, James Solowiej, Wade Diehl, You-Ai He, Xiu Yu, Asako Nagata, Todd VanArsdale, Brion W Murray

X Demographics

X Demographics

The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 266 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 266 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 40 15%
Student > Master 37 14%
Student > Ph. D. Student 35 13%
Student > Bachelor 25 9%
Other 21 8%
Other 38 14%
Unknown 70 26%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 53 20%
Chemistry 39 15%
Medicine and Dentistry 31 12%
Pharmacology, Toxicology and Pharmaceutical Science 26 10%
Agricultural and Biological Sciences 22 8%
Other 17 6%
Unknown 78 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 11 August 2023.
All research outputs
#1,583,275
of 25,006,193 outputs
Outputs from Molecular Cancer Therapeutics
#153
of 4,048 outputs
Outputs of similar age
#28,048
of 331,023 outputs
Outputs of similar age from Molecular Cancer Therapeutics
#4
of 62 outputs
Altmetric has tracked 25,006,193 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,048 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 331,023 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.